BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1684720)

  • 1. Neuroleptic effects on regional brain metabolism in first episode schizophrenics.
    Cleghorn JM; Szechtman H; Garnett ES; Brown GM; Nahmias C; Szechtman B; Kaplan R; Franco S
    Schizophr Res; 1991 Oct; 5(3):208-9. PubMed ID: 1684720
    [No Abstract]   [Full Text] [Related]  

  • 2. Regional metabolism in microsmic patients with schizophrenia.
    Clark C; Kopala L; Hurwitz T; Li D
    Can J Psychiatry; 1991 Nov; 36(9):645-50. PubMed ID: 1685350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of resting deoxyglucose metabolic values in PET studies of schizophrenia.
    Bartlett EJ; Barouche F; Brodie JD; Wolkin A; Angrist B; Rotrosen J; Wolf AP
    Psychiatry Res; 1991 May; 40(1):11-20. PubMed ID: 1946838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia.
    Cleghorn JM; Garnett ES; Nahmias C; Firnau G; Brown GM; Kaplan R; Szechtman H; Szechtman B
    Psychiatry Res; 1989 May; 28(2):119-33. PubMed ID: 2787515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of cortical activity in schizophrenia.
    Schroeder J; Buchsbaum MS; Siegel BV; Geider FJ; Haier RJ; Lohr J; Wu J; Potkin SG
    Psychol Med; 1994 Nov; 24(4):947-55. PubMed ID: 7892362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of attention on frontal distribution of delta activity and cerebral metabolic rate in schizophrenia.
    Guich SM; Buchsbaum MS; Burgwald L; Wu J; Haier R; Asarnow R; Nuechterlein K; Potkin S
    Schizophr Res; 1989; 2(6):439-48. PubMed ID: 2487185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apomorphine effects on brain metabolism in neuroleptic-naive schizophrenic patients.
    Cleghorn JM; Szechtman H; Garnett ES; Nahmias C; Brown GM; Kaplan RD; Szechtman B; Franco S
    Psychiatry Res; 1991 Oct; 40(2):135-53. PubMed ID: 1763143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of pharmacologic control in PET studies: effects of thiothixene and haloperidol on cerebral glucose utilization in chronic schizophrenia.
    Bartlett EJ; Wolkin A; Brodie JD; Laska EM; Wolf AP; Sanfilipo M
    Psychiatry Res; 1991 Oct; 40(2):115-24. PubMed ID: 1763142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlational patterns of cerebral glucose metabolism in never-medicated schizophrenics.
    Katz M; Buchsbaum MS; Siegel BV; Wu J; Haier RJ; Bunney WE
    Neuropsychobiology; 1996; 33(1):1-11. PubMed ID: 8821368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olfactory memory in unmedicated schizophrenics.
    Wu J; Buchsbaum MS; Moy K; Denlea N; Kesslak P; Tseng H; Plosnaj D; Hetu M; Potkin S; Bracha S
    Schizophr Res; 1993 Mar; 9(1):41-7. PubMed ID: 8068050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose metabolic correlates of continuous performance test performance in adults with a history of infantile autism, schizophrenics, and controls.
    Siegel BV; Nuechterlein KH; Abel L; Wu JC; Buchsbaum MS
    Schizophr Res; 1995 Sep; 17(1):85-94. PubMed ID: 8541254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward a brain map of auditory hallucinations.
    Cleghorn JM; Franco S; Szechtman B; Kaplan RD; Szechtman H; Brown GM; Nahmias C; Garnett ES
    Am J Psychiatry; 1992 Aug; 149(8):1062-9. PubMed ID: 1353314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered frontostriatal relationship in unmedicated schizophrenic patients.
    Biver F; Goldman S; Luxen A; Delvenne V; De Maertelaer V; De La Fuente J; Mendlewicz J; Lotstra F
    Psychiatry Res; 1995 Sep; 61(3):161-71. PubMed ID: 8545500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional brain metabolism during auditory hallucinations in chronic schizophrenia.
    Cleghorn JM; Garnett ES; Nahmias C; Brown GM; Kaplan RD; Szechtman H; Szechtman B; Franco S; Dermer SW; Cook P
    Br J Psychiatry; 1990 Oct; 157():562-70. PubMed ID: 2131139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontal and parietal metabolic disturbances in unipolar depression.
    Biver F; Goldman S; Delvenne V; Luxen A; De Maertelaer V; Hubain P; Mendlewicz J; Lotstra F
    Biol Psychiatry; 1994 Sep; 36(6):381-8. PubMed ID: 7803599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The psychobiology of first-episode schizophrenia.
    Waring EM
    Can J Psychiatry; 1995 Sep; 40(7 Suppl 2):S33-7. PubMed ID: 8564915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sight and insight: regional cerebral metabolic activity in schizophrenia visualised by positron emission tomography, and competing neurodevelopmental perspectives.
    Waddington JL
    Br J Psychiatry; 1990 May; 156():615-9. PubMed ID: 2095940
    [No Abstract]   [Full Text] [Related]  

  • 18. Positron emission tomography and subcortical glucose metabolism in schizophrenia.
    Resnick SM; Gur RE; Alavi A; Gur RC; Reivich M
    Psychiatry Res; 1988 Apr; 24(1):1-11. PubMed ID: 2899331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain hypometabolism of glucose in anorexia nervosa: normalization after weight gain.
    Delvenne V; Goldman S; De Maertelaer V; Simon Y; Luxen A; Lotstra F
    Biol Psychiatry; 1996 Oct; 40(8):761-8. PubMed ID: 8894069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics.
    Buchsbaum MS; Haier RJ; Potkin SG; Nuechterlein K; Bracha HS; Katz M; Lohr J; Wu J; Lottenberg S; Jerabek PA
    Arch Gen Psychiatry; 1992 Dec; 49(12):935-42. PubMed ID: 1360198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.